MaxCyte, Inc.
MXCT
$1.27
$0.032.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -24.66% | 32.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -24.66% | 32.21% | |||
| Cost of Revenue | 6.76% | -2.55% | |||
| Gross Profit | -30.76% | 42.04% | |||
| SG&A Expenses | 13.07% | 14.07% | |||
| Depreciation & Amortization | -6.20% | -2.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.53% | 11.36% | |||
| Operating Income | -65.43% | 10.63% | |||
| Income Before Tax | -86.82% | 50.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -86.82% | 50.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -86.82% | 50.50% | |||
| EBIT | -65.43% | 10.63% | |||
| EBITDA | -80.11% | 12.29% | |||
| EPS Basic | -87.16% | 50.61% | |||
| Normalized Basic EPS | -86.69% | 10.32% | |||
| EPS Diluted | -87.16% | 50.61% | |||
| Normalized Diluted EPS | -86.69% | 10.32% | |||
| Average Basic Shares Outstanding | -0.05% | 0.13% | |||
| Average Diluted Shares Outstanding | -0.05% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||